<h1>Kwality Pharmaceuticals Board Meeting Set to Approve Standalone and Consolidated Unaudited Financial Results</h1>
Kwality Pharmaceuticals Ltd has scheduled a Board of Directors meeting to review and approve the company's financial performance for the quarter ended June 30, 2026. The meeting is slated to take place on Monday, August 10, 2026, at 10:30 A.M., held at the company's registered office.
The primary agenda item for the Board of Directors includes considering and approving the Standalone and Consolidated Unaudited Financial Results of Kwality Pharmaceuticals Ltd for the period ending June 30, 2026.
In addition to the board meeting details, the company provided an update regarding the trading window for its shares. Following a previous intimation on June 29, 2026, the trading window for designated persons, their immediate relatives and other connected person(s) will remain closed until 48 hours after the declaration of Financial Results on August 10, 2026.
KPL Stock Price Movement
Kwality Pharmaceuticals Limited shares shed 1.11% in post-market trading today, settling at ₹2562. The stock traded a total volume of 12,762 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.